Form 8-K - Current report:
SEC Accession No. 0001437749-25-004505
Filing Date
2025-02-20
Accepted
2025-02-20 09:15:09
Documents
16
Period of Report
2025-02-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K omer20250212_8k.htm   iXBRL 8-K 25337
2 EXHIBIT 99.1 ex_777670.htm EX-99.1 37345
7 ex_777670img001.jpg GRAPHIC 3578
  Complete submission text file 0001437749-25-004505.txt   209678

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA omer-20250220.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20250220_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20250220_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20250220_pre.xml EX-101.PRE 11585
18 EXTRACTED XBRL INSTANCE DOCUMENT omer20250212_8k_htm.xml XML 2866
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 25643469
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)